Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.73 HKD | +1.97% | +12.17% | -7.30% |
04-26 | CSPC Pharmaceutical Group Limited Announces Highly Selective Mat2A Inhibitor Obtains Clinical Trial Approval in the U.S | CI |
04-24 | CSPC Pharmaceutical's EBT Buys 8.5 Million Shares | MT |
- Stock Market
- Equities
- 1093 Stock
- News CSPC Pharmaceutical Group Ltd.